Amanote Research

Amanote Research

    RegisterSign In

Type 3 ILCs in Lung Disease

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2019.00092
Full Text
Open PDF
Abstract

Available in full text

Categories
AllergyImmunology
Date

January 29, 2019

Authors
Amanda ArdainJames Zachary PorterfieldHenrik N. KløverprisAlasdair Leslie
Publisher

Frontiers Media SA


Related search

Von Willebrand Disease Type 3

2020English

Galectin-3 Is Associated With Restrictive Lung Disease and Interstitial Lung Abnormalities

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2016English

X-Linked Charcot-Marie-Tooth Disease Type 3

2020English

Two Cases of Von Willebrand Disease Type 3 in Consanguineous Chinese Families

Molecular genetics & genomic medicine
GeneticsMolecular Biology
2019English

Polyneuropathy in Gaucher Disease Type 1 and 3 – A Descriptive Case Series

Scientific Reports
Multidisciplinary
2019English

Multiple Glycosidase Deficiencies in a Case of Juvenile (Type 3) Gaucher Disease.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1978English

“Velcro-Type” Crackles Predict Specific Radiologic Features of Fibrotic Interstitial Lung Disease

BMC Pulmonary Medicine
PulmonaryRespiratory Medicine
2018English

Lung Involvement in Gaucher Disease

Case Reports in Clinical Practice
2020English

Gaucher Disease Type 1 First Recognized in an Elderly Patient With Thrombocytopenia and Lung Adenocarcinoma

Clinical Case Reports
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy